The Jaguar Animal Health (JAGX) Earns Daily Coverage Optimism Score of 0.13

The Jaguar Animal Health (JAGX) Earns Daily Coverage Optimism Score of 0.13

Shares of Jaguar Animal Health (JAGX) traded up 3.8636% during trading on Friday, hitting $0.6855. The company had a trading volume of 132,588 shares. The stock’s market cap is $9.90 million. The firm has a 50 day moving average of $0.77 and a 200 day moving average of $0.82. Jaguar Animal Health has a 12-month low of $0.50 and a 12-month high of $3.79.

Headlines about Jaguar Animal Health (NASDAQ:JAGX) have trended somewhat positive this week, Alpha One Sentiment Analysis reports. The research firm, a subsidiary of Accern, rates the sentiment of media coverage by analyzing more than 20 million blog and news sources in real time. Alpha One ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Jaguar Animal Health earned a media sentiment score of 0.13 on Alpha One’s scale. Alpha One also gave press coverage about the biotechnology company an impact score of 0 out of 100, indicating that recent media coverage is extremely unlikely to have an effect on the company’s share price in the immediate future.

Jaguar Animal Health Company Profile

Jaguar Animal Health, Inc is an animal health company. It is focused on developing and commercializing gastrointestinal products for companion and production animals, foals, and horses. Canalevia is its prescription drug product candidate, intended for treatment of various forms of diarrhea in dogs. Canalevia is a canine-specific formulation of crofelemer, an active pharmaceutical ingredient (API) isolated and purified from the Croton lechleri tree.new TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “NASDAQ:JAGX”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Related posts

Leave a Comment